For more context about Medvi, the initial article, and what it was missing -- though the NYT did update the piece today with more info about Medvi's regulatory/legal troubles -- see this thread:

bsky.app/profile/mharrisondupre.bsky.social/post/3mitok43pkc2c

April 10, 2026 - 00:08 UTC

1
0
8
Medvi's "response to external speculation," published yesterday, focuses heavily on the FDA warning it received in Feb 2026 regarding multiple violations on the website Medvi(.io.)

It's true that Medvi was one of several similar companies to receive a warning amid a broader FDA crackdown...
1
0
6
...Medvi is also saying that at the time Medvi(.io) was in violation of FDA guidelines, per the agency, it was actually operated by an affiliate marketer "whose website contained outdated copy":
1
0
2